NLS Pharmaceutics Ltd. reported overdue payments totaling $492,723.23 to Cambrex Corporation as of December 1, 2023, and $793,112.46 to Clinilabs, Inc. for services completed, along with a settlement for $1,007,700.50 with CoreRX, Inc. on December 11, 2023.